Works matching AU Mol, Peter G. M.

Results: 69

Mixed Impact of Direct Healthcare Professional Communications When Considering Proximal Outcomes and the Targeted Population: A Systematic Review.

Published in:

Pharmacoepidemiology & Drug Safety, 2025, v. 34, n. 3, p. 1, doi. 10.1002/pds.70135

By:

de Vries, Esther;
Denig, Petra;
Monster, Taco B. M.;
Mol, Peter G. M.

Publication type:

Article

Do efficacy results obtained from randomized controlled trials translate to effectiveness data from observational studies for relapsing–remitting multiple sclerosis?

Published in:

Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 5, p. 1, doi. 10.1002/pds.5810

By:

Verweij, Stefan;
Ahmed, Wouter;
Zhou, Guiling;
Mavridis, Dimitris;
Nikolakopoulos, Stavros;
Elferink, Andre J.;
Rengerink, Katrien Oude;
Bijlsma, Maarten J.;
Mol, Peter G. M.;
Hak, Eelko

Publication type:

Article

Precision medicine in diabetes and diabetic kidney disease: Regulatory considerations.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, p. 19, doi. 10.1111/dom.13453

By:

Mol, Peter G. M.;
Thompson, Aliza;
Heerspink, Hiddo J. L.;
Leufkens, Hubert G. M.

Publication type:

Article

What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study.

Published in:

Drug Safety, 2023, v. 46, n. 3, p. 243, doi. 10.1007/s40264-022-01270-4

By:

Roldan Munoz, Sonia;
Postmus, Douwe;
de Vries, Sieta T.;
Gross-Martirosyan, Liana;
Bahri, Priya;
Hillege, Hans;
Mol, Peter G. M.

Publication type:

Article

Factors Influencing Preferences and Responses Towards Drug Safety Communications: A Conjoint Experiment Among Hospital-Based Healthcare Professionals in the Netherlands.

Published in:

2022

By:

de Vries, Esther;
Bakker, Elisabeth;
Monster, Taco B. M.;
Denig, Petra;
Mol, Peter G. M.

Publication type:

journal article

Handling of New Drug Safety Information in the Dutch Hospital Setting: A Mixed Methods Approach.

Published in:

Drug Safety, 2022, v. 45, n. 4, p. 369, doi. 10.1007/s40264-022-01149-4

By:

de Vries, Esther;
Bakker, Elisabeth;
Francisca, Remy D. C.;
Croonen, Stijn;
Denig, Petra;
Mol, Peter G. M.

Publication type:

Article

Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK.

Published in:

2021

By:

de Vries, Sieta T.;
Denig, Petra;
Andrić, Adriana;
Dimov Di Giusti, Marina;
Ptaszynska-Neophytou, Alicia;
Härmark, Linda;
Mol, Peter G. M.;
IMI Web-RADR Work Package 3b Consortium and SCOPE Joint Action Work Package 4

Publication type:

journal article

Capturing Data in Rare Disease Registries to Support Regulatory Decision Making: A Survey Study Among Industry and Other Stakeholders.

Published in:

Drug Safety, 2021, v. 44, n. 8, p. 853, doi. 10.1007/s40264-021-01081-z

By:

Jonker, Carla J.;
de Vries, Sieta T.;
van den Berg, H. Marijke;
McGettigan, Patricia;
Hoes, Arno W.;
Mol, Peter G. M.

Publication type:

Article

Dissemination of Direct Healthcare Professional Communications on Medication Errors for Medicinal Products in the EU: An Explorative Study on Relevant Factors.

Published in:

Drug Safety, 2021, v. 44, n. 1, p. 73, doi. 10.1007/s40264-020-00995-4

By:

Hoeve, Christina E.;
de Vries, Esther;
Mol, Peter G. M.;
Sturkenboom, Miriam C. J. M.;
Straus, Sabine M. J. M.

Publication type:

Article

Correction to: Safety Communication Tools and Healthcare Professionals' Awareness of Specific Drug Safety Issues in Europe: A Survey Study.

Published in:

2020

By:

de Vries, Sieta T.;
van der Sar, Maartje J. M.;
Coleman, Anna Marie;
Escudero, Yvette;
Rodríguez Pascual, Alfonso;
Maciá Martínez, Miguel-Ángel;
Cupelli, Amelia;
Baldelli, Ilaria;
Šipić, Ivana;
Andrić, Adriana;
Michan, Line;
Denig, Petra;
Mol, Peter G. M.

Publication type:

Correction Notice

Drug Safety Issues Covered by Lay Media: A Cohort Study of Direct Healthcare Provider Communications Sent between 2001 and 2015 in The Netherlands.

Published in:

2020

By:

de Vries, Esther;
Denig, Petra;
de Vries, Sieta T.;
Monster, Taco B. M.;
Hugtenburg, Jacqueline G.;
Mol, Peter G. M.

Publication type:

journal article

Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey Study.

Published in:

2020

By:

de Vries, Sieta T.;
Denig, Petra;
Ekhart, Corine;
Mol, Peter G. M.;
van Puijenbroek, Eugene P.

Publication type:

journal article

Authors' Reply to Ravi Jandhyala's Comment on "Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Assessments".

Published in:

2019

By:

McGettigan, Patricia;
Olmo, Carla Alonso;
Plueschke, Kelly;
Castillon, Mireia;
Zondag, Daniel;
Bahri, Priya;
Kurz, Xavier;
Mol, Peter G. M.

Publication type:

Letter

Correction to: Patient Registries: An Underused Resource for Medicines Evaluation : Operational proposals for increasing the use of patient registries in regulatory assessments.

Published in:

2019

By:

McGettigan, Patricia;
Alonso Olmo, Carla;
Plueschke, Kelly;
Castillon, Mireia;
Nogueras Zondag, Daniel;
Bahri, Priya;
Kurz, Xavier;
Mol, Peter G. M.

Publication type:

corrected article

Patient Registries: An Underused Resource for Medicines Evaluation : Operational proposals for increasing the use of patient registries in regulatory assessments.

Published in:

2019

By:

McGettigan, Patricia;
Alonso Olmo, Carla;
Plueschke, Kelly;
Castillon, Mireia;
Nogueras Zondag, Daniel;
Bahri, Priya;
Kurz, Xavier;
Mol, Peter G. M.

Publication type:

journal article

Use of a Patient-Friendly Terms List in the Adverse Drug Reaction Report Form: A Database Study.

Published in:

2019

By:

de Vries, Sieta T.;
Harrison, Judy;
Revelle, Patrick;
Ptaszynska-Neophytou, Alicia;
Radecka, Anna;
Ragunathan, Gowthamei;
Tregunno, Phil;
Denig, Petra;
Mol, Peter G. M.

Publication type:

journal article

Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR.

Published in:

2019

By:

Pierce, Carrie E.;
de Vries, Sieta T.;
Bodin-Parssinen, Stephanie;
Härmark, Linda;
Tregunno, Phil;
Lewis, David J.;
Maskell, Simon;
Van Eemeren, Raphael;
Ptaszynska-Neophytou, Alicia;
Newbould, Victoria;
Dasgupta, Nabarun;
Wisniewski, Antoni F. Z.;
Gama, Sara;
Mol, Peter G. M.

Publication type:

journal article

Interest in a Mobile App for Two-Way Risk Communication: A Survey Study Among European Healthcare Professionals and Patients.

Published in:

2018

By:

de Vries, Sieta T.;
Denig, Petra;
Lasheras Ruiz, Carmen;
Houÿez, François;
Wong, Lisa;
Sutcliffe, Alastair;
Mol, Peter G. M.;
on behalf of IMI Web-RADR Work Package 3b Consortium;
IMI Web-RADR Work Package 3b Consortium

Publication type:

journal article

Safety Communication Tools and Healthcare Professionals' Awareness of Specific Drug Safety Issues in Europe: A Survey Study.

Published in:

2018

By:

de Vries, Sieta T.;
van der Sar, Maartje J. M.;
Coleman, Anna Marie;
Escudero, Yvette;
Rodríguez Pascual, Alfonso;
Maciá Martínez, Miguel-Ángel;
Cupelli, Amelia;
Baldelli, Ilaria;
Šipić, Ivana;
Andrić, Adriana;
Michan, Line;
Denig, Petra;
Mol, Peter G. M.;
on behalf of SCOPE work package 6;
SCOPE work package 6

Publication type:

journal article

The RIMES Statement: A Checklist to Assess the Quality of Studies Evaluating Risk Minimization Programs for Medicinal Products.

Published in:

2018

By:

Smith, Meredith Y.;
Russell, Andrea;
Bahri, Priya;
Mol, Peter G. M.;
Frise, Sarah;
Freeman, Emily;
Morrato, Elaine H.

Publication type:

journal article

Communication on Safety of Medicines in Europe: Current Practices and General Practitioners' Awareness and Preferences.

Published in:

2017

By:

Vries, Sieta;
Sar, Maartje;
Cupelli, Amelia;
Baldelli, Ilaria;
Coleman, Anna;
Montero, Dolores;
Šipić, Ivana;
Andrić, Adriana;
Wennberg, Annika;
Ahlqvist-Rastad, Jane;
Denig, Petra;
Mol, Peter;
de Vries, Sieta T;
van der Sar, Maartje J M;
Coleman, Anna Marie;
Šipić, Ivana;
Andrić, Adriana;
Mol, Peter G M;
SCOPE Work Package 6

Publication type:

journal article

Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study.

Published in:

2017

By:

Vries, Sieta;
Wong, Lisa;
Sutcliffe, Alastair;
Houÿez, François;
Ruiz, Carmen;
Mol, Peter;
de Vries, Sieta T;
Houÿez, François;
Ruiz, Carmen Lasheras;
Mol, Peter G M;
IMI Web-RADR Work Package 3b Consortium

Publication type:

journal article

The Additional Value of an E-Mail to Inform Healthcare Professionals of a Drug Safety Issue: A Randomized Controlled Trial in the Netherlands.

Published in:

2013

By:

Piening, Sigrid;
de Graeff, Pieter A.;
Straus, Sabine M. J. M.;
Haaijer-Ruskamp, Flora M.;
Mol, Peter G. M.

Publication type:

journal article

Development and Initial Validation of a Patient-Reported Adverse Drug Event Questionnaire.

Published in:

2013

By:

de Vries, Sieta T.;
Mol, Peter G. M.;
de Zeeuw, Dick;
Haaijer-Ruskamp, Flora M.;
Denig, Petra

Publication type:

journal article

Healthcare professionals' self-reported experiences and preferences related to direct healthcare professional communications: a survey conducted in the Netherlands.

Published in:

2012

By:

Piening S;
Haaijer-Ruskamp FM;
de Graeff PA;
Straus SM;
Mol PG;
Piening, Sigrid;
Haaijer-Ruskamp, Flora M;
de Graeff, Pieter A;
Straus, Sabine M J M;
Mol, Peter G M

Publication type:

journal article

Healthcare Professionals' Self-Reported Experiences and Preferences Related to Direct Healthcare Professional Communications. A Survey Conducted in the Netherlands.

Published in:

Drug Safety, 2012, v. 35, n. 11, p. 1061, doi. 10.2165/11635750-000000000-00000

By:

Piening, Sigrid;
Haaijer-Ruskamp, Flora M.;
de Graeff, Pieter A.;
Straus, Sabine M. J. M.;
Mol, Peter G. M.

Publication type:

Article

Prescribing of rosiglitazone and pioglitazone following safety signals: analysis of trends in dispensing patterns in the Netherlands from 1998 to 2008.

Published in:

2012

By:

Ruiter R;
Visser LE;
van Herk-Sukel MP;
Geelhoed-Duijvestijn PH;
de Bie S;
Straus SM;
Mol PG;
Romio SA;
Herings RM;
Stricker BH;
Ruiter, Rikje;
Visser, Loes E;
van Herk-Sukel, Myrthe P P;
Geelhoed-Duijvestijn, Petronella H;
de Bie, Sandra;
Straus, Sabine M J M;
Mol, Peter G M;
Romio, Silvana A;
Herings, Ron M C;
Stricker, Bruno H Ch

Publication type:

journal article

Impact of safety-related regulatory action on clinical practice: a systematic review.

Published in:

2012

By:

Piening S;
Haaijer-Ruskamp FM;
de Vries JT;
van der Elst ME;
de Graeff PA;
Straus SM;
Mol PG;
Piening, Sigrid;
Haaijer-Ruskamp, Flora M;
de Vries, Jonie T N;
van der Elst, Menno E;
de Graeff, Pieter A;
Straus, Sabine M J M;
Mol, Peter G M

Publication type:

journal article

Effect of safety issues with HIV drugs on the approval process of other drugs in the same class: an analysis of European Public Assessment Reports.

Published in:

2011

By:

Arnardottir AH;
Haaijer-Ruskamp FM;
Straus SM;
de Graeff PA;
Mol PG;
Arnardottir, Arna H;
Haaijer-Ruskamp, Flora M;
Straus, Sabine M J;
de Graeff, Pieter A;
Mol, Peter G M

Publication type:

journal article

Preventable and non-preventable adverse drug events in hospitalized patients: a prospective chart review in the Netherlands.

Published in:

2011

By:

Dequito AB;
Mol PG;
van Doormaal JE;
Zaal RJ;
van den Bemt PM;
Haaijer-Ruskamp FM;
Kosterink JG;
Dequito, Aileen B;
Mol, Peter G M;
van Doormaal, Jasperien E;
Zaal, Rianne J;
van den Bemt, Patricia M L A;
Haaijer-Ruskamp, Flora M;
Kosterink, Jos G W

Publication type:

journal article

Communication in drug safety: a report from an interactive debate held at the 10th annual meeting of the international society of pharmacovigilance (ISoP), 2010.

Published in:

2011

By:

Bahri P;
Mol PG;
Théophile H;
Edwards IR;
Hugman BP;
Bahri, Priya;
Mol, Peter G M;
Théophile, Hélène;
Edwards, I Ralph;
Hugman, Bruce P J

Publication type:

journal article

A decade of safety-related regulatory action in the Netherlands: a retrospective analysis of direct healthcare professional communications from 1999 to 2009.

Published in:

2010

By:

Mol PG;
Straus SM;
Piening S;
de Vries JT;
de Graeff PA;
Haaijer-Ruskamp FM;
Mol, Peter G M;
Straus, Sabine M J M;
Piening, Sigrid;
de Vries, Jonie T N;
de Graeff, Pieter A;
Haaijer-Ruskamp, Flora M

Publication type:

journal article

Comment on: "The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022".

Published in:

2024

By:

de Vries, Sieta T.;
Al-Mugoter, Noral Huda S.;
Petkoska, Irena;
Verweij, Stefan;
Elferink, André J. A.;
Mol, Peter G. M.

Publication type:

Letter

Real‐World Evidence to Support EU Regulatory Decision Making—Results From a Pilot of Regulatory Use Cases.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 5, p. 1188, doi. 10.1002/cpt.3355

By:

Prilla, Stefanie;
Groeneveld, Sophie;
Pacurariu, Alexandra;
Restrepo‐Méndez, María Clara;
Verpillat, Patrice;
Torre, Carla;
Gartner, Christian;
Mol, Peter G. M.;
Naumann‐Winter, Frauke;
Breen, Kieran C.;
Gault, Nathalie;
Gross‐Martirosyan, Liana;
Benchetrit, Sylvie;
Aylward, Brian;
Stoyanova‐Beninska, Violeta;
O'Donovan, Maura;
Straus, Sabine;
Kjaer, Jesper;
Arlett, Peter

Publication type:

Article

The Evolution of Drug Regulatory Sciences in the Netherlands: More than a Country Report.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 1, p. 64, doi. 10.1002/cpt.3275

By:

Pasmooij, Anna M. G.;
Mol, Peter G. M.;
Bot, Jacob Cornelis;
Leufkens, Hubert G. M.

Publication type:

Article

Contribution of Real‐World Evidence in European Medicines Agency's Regulatory Decision Making.

Published in:

Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 1, p. 135, doi. 10.1002/cpt.2766

By:

Bakker, Elisabeth;
Plueschke, Kelly;
Jonker, Carla J.;
Kurz, Xavier;
Starokozhko, Viktoriia;
Mol, Peter G. M.

Publication type:

Article

Limited effect of patient and disease characteristics on compliance with hospital antimicrobial guidelines.

Published in:

European Journal of Clinical Pharmacology, 2006, v. 62, n. 4, p. 297, doi. 10.1007/s00228-005-0058-y

By:

Mol, Peter G. M.;
Denig, Petra;
Gans, Rijk O. B.;
NannanPanday, Prashant V.;
Degener, John E.;
Laseur, Marian;
Haaijer-Ruskamp, Flora M.

Publication type:

Article

The role of stakeholder involvement in the evolving EU HTA process: Insights generated through the European Access Academy's multi-stakeholder preconvention questionnaire.

Published in:

Journal of Market Access & Health Policy, 2023, v. 11, n. 1, p. 1, doi. 10.1080/20016689.2023.2217543

By:

Van Haesendonck, Lauren;
Ruof, Jörg;
Desmet, Thomas;
Van Dyck, Walter;
Simoens, Steven;
Huys, Isabelle;
Giuliani, Rosa;
Toumi, Mondher;
Dierks, Christian;
Dierks, Juliana;
Cardone, Antonella;
Houÿez, Francois;
Pavlovic, Mira;
Berntgen, Michael;
Mol, Peter G. M.;
Schiel, Anja;
Goettsch, Wim;
Gianfrate, Fabrizio;
Capri, Stefano;
Ryan, James

Publication type:

Article

Adherence barriers to antimicrobial treatment guidelines in teaching hospital, the Netherlands.

Published in:

2004

By:

Mol, Peter G. M.;
Rutten, Willem J. M. J.;
Gans, Rijk O. B.;
Degener, John E.;
Haaijer-Ruskamp, Flora M.

Publication type:

journal article

Effect of antithrombotic stewardship on the efficacy and safety of antithrombotic therapy during and after hospitalization.

Published in:

PLoS ONE, 2020, v. 15, n. 6, p. 1, doi. 10.1371/journal.pone.0235048

By:

Dreijer, Albert R.;
Kruip, Marieke J. H. A.;
Diepstraten, Jeroen;
Polinder, Suzanne;
Brouwer, Rolf;
Mol, Peter G. M.;
Croles, F. Nanne;
Kragten, Esther;
Leebeek, Frank W. G.;
van den Bemt, Patricia M. L. A.

Publication type:

Article

Improving compliance with hospital antibiotic guidelines: a time-series intervention analysis.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 55, n. 4, p. 550, doi. 10.1093/jac/dki037

By:

Peter G. M. Mol;
Jaap E. Wieringa;
Prashant V. NannanPanday;
Rijk O. B. Gans;
John E. Degener;
M. Laseur;
Flora M. Haaijer-Ruskamp

Publication type:

Article

Computerized physician order entry (CPOE) system: expectations and experiences of users.

Published in:

Journal of Evaluation in Clinical Practice, 2010, v. 16, n. 4, p. 738, doi. 10.1111/j.1365-2753.2009.01187.x

By:

Van Doormaal, Jasperien E.;
Mol, Peter G. M.;
Zaal, Rianne J.;
Van Den Bemt, Patricia M. L. A.;
Kosterink, Jos G. W.;
Vermeulen, Karin M.;
Haaijer‐Ruskamp, Flora M.

Publication type:

Article

Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study.

Published in:

Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.617409

By:

Roldan Munoz, Sonia;
Postmus, Douwe;
de Vries, Sieta T.;
Arnardottir, Arna H.;
Dolu, İlknur;
Hillege, Hans;
Mol, Peter G. M.

Publication type:

Article

Healthcare professionals' level of medication knowledge in Africa: a systematic review.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 12, p. 2729, doi. 10.1111/bcp.13746

By:

Berhe, Derbew Fikadu;
Taxis, Katja;
Haaijer‐Ruskamp, Flora M.;
Mol, Peter G. M.

Publication type:

Article

Impact of adverse drug events and treatment satisfaction on patient adherence with antihypertensive medication - a study in ambulatory patients.

Published in:

British Journal of Clinical Pharmacology, 2017, v. 83, n. 9, p. 2107, doi. 10.1111/bcp.13312

By:

Berhe, Derbew Fikadu;
Taxis, Katja;
Haaijer-Ruskamp, Flora M.;
Mulugeta, Afework;
Mengistu, Yewondwossen Tadesse;
Burgerhof, Johannes G. M.;
Mol, Peter G. M.

Publication type:

Article

Understanding drug preferences, different perspectives.

Published in:

British Journal of Clinical Pharmacology, 2015, v. 79, n. 6, p. 978, doi. 10.1111/bcp.12566

By:

Mol, Peter G. M.;
Arnardottir, Arna H.;
Straus, Sabine M. J.;
Graeff, Pieter A.;
Haaijer‐Ruskamp, Flora M.;
Quik, Elise H.;
Krabbe, Paul F. M.;
Denig, Petra

Publication type:

Article

Adverse drug event patterns experienced by patients with diabetes: A diary study in primary care.

Published in:

Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 9, p. 1175, doi. 10.1002/pds.4839

By:

Denig, Petra;
Puijenbroek, Eugène P.;
Soliman, Nashwa;
Mol, Peter G. M.;
Vries, Sieta T.

Publication type:

Article

Critically reviewing impact of regulatory actions, not just FDA's.

Published in:

Pharmacoepidemiology & Drug Safety, 2014, v. 23, n. 1, p. 105, doi. 10.1002/pds.3509

By:

Mol, Peter G. M.

Publication type:

Article

Comparison of potential risk factors for medication errors with and without patient harm.

Published in:

Pharmacoepidemiology & Drug Safety, 2010, v. 19, n. 8, p. 825, doi. 10.1002/pds.1977

By:

Zaal, Rianne J.;
van Doormaal, Jasperien E.;
Lenderink, Albert W.;
Mol, Peter G. M.;
Kosterink, Jos G.W.;
Egberts, Toine C. G.;
Haaijer-Ruskamp, Flora M.;
van den Bemt, Patricia M. L. A.

Publication type:

Article

Reliability of the assessment of preventable adverse drug events in daily clinical practice.

Published in:

Pharmacoepidemiology & Drug Safety, 2008, v. 17, n. 7, p. 645, doi. 10.1002/pds.1586

By:

van Doormaal, Jasperien E.;
Mol, Peter G. M.;
van den Bemt, Patricia M. L. A.;
Zaal, Rianne J.;
Egberts, Antoine C. G.;
Kosterink, Jos G. W.;
Haaijer-Ruskamp, Flora M.

Publication type:

Article